| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 111.923.342 $ | +24.037.258 $ | +516,2 % | 9 | 112.502.515 $ | +62.623.910 $ | +94,3 % | 8 | 63.134.485 $ | +17.375.177 $ | +59,4 % | 8 | ||||
| Praxis Precision Medicines, Inc. | PRAX | → 0 | Neutral | 32.470.630 $ | +2.766.438 $ | +9,3 % | 1 | 29.704.192 $ | +22.665.527 $ | +322,0 % | 1 | 7.038.665 $ | +759.170 $ | +12,1 % | 1 |
| Cidara Therapeutics, Inc. | → 0 | 23.945.360 $ | +13.564.593 $ | +130,7 % | 1 | 10.380.767 $ | +5.509.767 $ | +113,1 % | 1 | ||||||
| Protara Therapeutics, Inc. | TARA | → 0 | Neutral | 14.768.537 $ | -340.158 $ | -2,3 % | 1 | 15.108.695 $ | +5.804.045 $ | +62,4 % | 1 | 9.304.650 $ | +2.823.480 $ | +43,6 % | 1 |
| SUTRO BIOPHARMA, INC. | STRO | → 0 | Neutral | 12.757.906 $ | +9.148.066 $ | +253,4 % | 1 | ||||||||
| HERON THERAPEUTICS, INC. /DE/ | HRTX | → 0 | Neutral | 7.003.507 $ | -4.375.770 $ | -38,5 % | 1 | 11.379.277 $ | +350.132 $ | +3,2 % | 1 | 11.029.145 $ | -3.433.415 $ | -23,7 % | 1 |
| Evommune, Inc. | EVMN | → 0 | Neutral | 10.259.402 $ | +1.583.774 $ | +18,3 % | 1 | 8.675.628 $ | +8.675.628 $ | 1 | |||||
| MapLight Therapeutics, Inc. | MPLT | → 0 | Schwach | 10.020.515 $ | +846.227 $ | +9,2 % | 1 | 9.174.288 $ | +9.174.288 $ | 1 | |||||
| TENAX THERAPEUTICS, INC. | TENX | → 0 | Neutral | 9.327.495 $ | +8.311.666 $ | +818,2 % | 1 | ||||||||
| Abivax S.A. | ABVX | → 0 | Schwach | 8.573.950 $ | -461.335 $ | -5,1 % | 1 | 9.035.285 $ | +3.568.659 $ | +65,3 % | 1 | 5.466.626 $ | +5.466.626 $ | 1 | |
| Rezolute, Inc. | RZLT | → 0 | Neutral | 7.050.000 $ | +3.705.000 $ | +110,8 % | 1 | ||||||||
| Immix Biopharma, Inc. | IMMX | → 0 | Neutral | 6.741.400 $ | +6.558.350 $ | +3.582,8 % | 1 | ||||||||
| Mineralys Therapeutics, Inc. | MLYS | → 0 | Neutral | 5.479.790 $ | -1.178.962 $ | -17,7 % | 1 | 6.658.752 $ | +4.296.414 $ | +181,9 % | 1 | ||||
| Jasper Therapeutics, Inc. | JSPR | → 0 | Schwach | 6.205.880 $ | -1.751.865 $ | -22,0 % | 1 | ||||||||
| 111.923.342 $ | +24.037.258 $ | +516,2 % | 9 | 112.502.515 $ | +62.623.910 $ | +94,3 % | 8 | 63.134.485 $ | +17.375.177 $ | +59,4 % | 8 | ||||